Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2978
Gene Symbol: GUCA1A
GUCA1A
0.120 Biomarker phenotype BEFREE Surprisingly, we found that GCAP2 is expressed in cones and can regulate light sensitivity and response kinetics as well as light adaptation of GCAP1-deficient mouse cones. 29549122 2018
Entrez Id: 1261
Gene Symbol: CNGA3
CNGA3
0.120 GeneticVariation phenotype BEFREE Mutations in the CNGA3 gene have been associated with complete and incomplete forms of total colour blindness (achromatopsia), a disorder characterized by reduced visual acuity, lack of colour discrimination, photophobia and nystagmus. 18445228 2008
Entrez Id: 1261
Gene Symbol: CNGA3
CNGA3
0.120 GeneticVariation phenotype BEFREE Mutations in the CNGA3 gene have been associated with complete and incomplete forms of achromatopsia (ACHR), a congenital, autosomal recessively inherited retinal disorder characterized by lack of color discrimination, reduced visual acuity, nystagmus, and photophobia. 18521937 2008
Entrez Id: 2979
Gene Symbol: GUCA1B
GUCA1B
0.120 Biomarker phenotype BEFREE This chapter focuses on recent data obtained from biochemical and electrophysiological studies of GCAP1/GCAP2 knockout mice and other GCAP transgenic mice, addressing: 1. the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies. 12596933 2002
Entrez Id: 2978
Gene Symbol: GUCA1A
GUCA1A
0.120 Biomarker phenotype BEFREE This chapter focuses on recent data obtained from biochemical and electrophysiological studies of GCAP1/GCAP2 knockout mice and other GCAP transgenic mice, addressing: 1. the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies. 12596933 2002
Entrez Id: 6121
Gene Symbol: RPE65
RPE65
0.120 Biomarker phenotype HPO
Entrez Id: 1261
Gene Symbol: CNGA3
CNGA3
0.120 Biomarker phenotype HPO
Entrez Id: 2979
Gene Symbol: GUCA1B
GUCA1B
0.120 Biomarker phenotype HPO
Entrez Id: 1261
Gene Symbol: CNGA3
CNGA3
0.120 GeneticVariation phenotype CLINVAR
Entrez Id: 2978
Gene Symbol: GUCA1A
GUCA1A
0.120 Biomarker phenotype HPO
Entrez Id: 326
Gene Symbol: AIRE
AIRE
0.110 Biomarker phenotype BEFREE Topical tacrolimus is effective in reducing the photophobia in patients with APS-1-associated keratitis, but showed no effects on the severity of keratitis. 28137823 2017
Entrez Id: 26504
Gene Symbol: CNNM4
CNNM4
0.110 GeneticVariation phenotype BEFREE The entire coding region of CNNM4 gene was sequenced for detection of potential mutations.ResultsOcular examinations showed nystagmus and photophobia along with early onset visual impairment. 27419834 2016
Entrez Id: 6898
Gene Symbol: TAT
TAT
0.110 GeneticVariation phenotype BEFREE In the present study we report the clinical features and the molecular genetic investigation of the tyrosine aminotransferase (TAT) gene in a young girl from Croatia with Richner-Hanhart syndrome, mainly suffering from photophobia, hyperkeratosis of the palmes and soles and slight neurological abnormalities. 21145993 2011
Entrez Id: 8787
Gene Symbol: RGS9
RGS9
0.110 GeneticVariation phenotype BEFREE Recently, it was discovered that subjects who showed a prolonged response suppression on their electroretinogram (ERG) and had symptoms of photophobia, problems adjusting to bright light, and difficulties seeing moving objects shared a mutation in the RGS9 (regulator of G-protein signaling 9) gene that is involved in the deactivation of photoreceptor responses. 17826834 2007
Entrez Id: 2068
Gene Symbol: ERCC2
ERCC2
0.110 AlteredExpression phenotype BEFREE Our results indicate that XPD overexpression in SK-MG-4 cells leads to cisplatin resistance without affecting the nucleotide excision repair activity or UV light sensitivity of the cell. 12359753 2002
Entrez Id: 5429
Gene Symbol: POLH
POLH
0.110 Biomarker phenotype BEFREE Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase eta. 10871396 2000
Entrez Id: 1497
Gene Symbol: CTNS
CTNS
0.110 GeneticVariation phenotype BEFREE Benign or nonnephropathic cystinosis, with symptoms related only to corneal crystals and photophobia, has been associated with two other CTNS mutations. 10571941 1999
Entrez Id: 2073
Gene Symbol: ERCC5
ERCC5
0.110 Biomarker phenotype BEFREE The human XPG (ERCC5) gene encodes a large acidic protein that corrects the ultraviolet light sensitivity of cells from both xeroderma pigmentosum complementation group G and rodent ERCC group 5. 7951246 1994
Entrez Id: 326
Gene Symbol: AIRE
AIRE
0.110 Biomarker phenotype HPO
Entrez Id: 6898
Gene Symbol: TAT
TAT
0.110 Biomarker phenotype HPO
Entrez Id: 26504
Gene Symbol: CNNM4
CNNM4
0.110 Biomarker phenotype HPO
Entrez Id: 2068
Gene Symbol: ERCC2
ERCC2
0.110 Biomarker phenotype HPO
Entrez Id: 5429
Gene Symbol: POLH
POLH
0.110 Biomarker phenotype HPO
Entrez Id: 8787
Gene Symbol: RGS9
RGS9
0.110 Biomarker phenotype HPO
Entrez Id: 1497
Gene Symbol: CTNS
CTNS
0.110 Biomarker phenotype HPO